Faconi Anemia Clinical Trials Faconi Anemia RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
Conditions:   ARID1A Gene Mutation;   ATM Gene Mutation;   ATR Gene Mutation;   Bile Duct Adenocarcinoma;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   BRIP1 Gene Mutation;   CHEK2 Gene Mutation;   EMSY Gene Mutation;   Fanconi Anemia Complementation Group Gene Mutation;   Metast atic Bile Duct Carcinoma;   MRE11 Gene Mutation;   NBN Gene Mutation;   PALB2 Gene Mutation;   PTEN Gene Deletion;   RAD51 Gene Mutation Intervention:   Drug: Olaparib Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials